SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.

Shenzhen Weiguang Biological Products Co., Ltd.

002880

CNE100002Q58

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-06-20 pm EDT			5-day change	1st Jan Change
28.42 ^CNY	+1.72%		-2.34%	-19.10%

Jun. 03	Weiguang Biological Products Gets Nod for Human Prothrombin Complex	MT
May. 20	Shenzhen Weiguang Biological Products Co., Ltd. Approves Dividend for the Year 2023	CI

Shenzhen Weiguang Biological Products Co., Ltd. Approves Cash Dividend for the Year 2020

May 21, 2021 at 03:33 pm EDT

Shenzhen Weiguang Biological Products Co.,Ltd announced at the AGM held on May 20, 2021 has approved a cash dividend (tax included) of CNY 2.50000000 per ten shares for the year 2020.

Latest news about Shenzhen Weiguang Biological Products Co., Ltd.

Weiguang Biological Products Gets Nod for Human Prothrombin Complex	Jun. 03	MT
Shenzhen Weiguang Biological Products Co., Ltd. Approves Dividend for the Year 2023	May. 20	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for the Year 2023	Apr. 26	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Weiguang Biological Products Gets Registration Certificate for Human Coagulation Factor VIII Drug	Nov. 06	MT
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemdented (A Shares) for 2023, Payable on 31 October 2023	23-10-24	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Interim Dividend for Year 2023	23-09-18	CI
Shenzhen Weiguang Biological Products Co., Ltd.(XSEC:002880) added to S&P Global BMI Index	23-09-18	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023	23-08-25	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Weiguang Biological Products Halts Trading on Potential Change in Control	23-05-29	MT
Shenzhen Liying Biotechnology Co., Ltd announced that it has received funding from Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd. and other investors	23-05-23	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
Shenzhen Liying Biotechnology Co., Ltd announced that it has received funding from Goldport Capital, Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd. and other investors	23-04-05	CI
Weiguang Biological Products to Buy 80% of Plasma Collection Firm For 23 Million Yuan	23-01-09	MT
Shenzhen Weiguang Biological Products Co., Ltd. agreed to acquire 80% stake in Ankang Huitian Plasmapheresis Station Co., Ltd. from Xia Yuzhen for CNY 22.8 million	23-01-09	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-29	CI
Shenzhen Weiguang Biological Products Co., Ltd. Announces Cash Dividend on A Shares for 2021, Payable on 8 July 2022	22-07-03	CI
Shenzhen Weiguang Biological Products Co., Ltd.(XSEC:002880) dropped from S&P Global BMI Index	22-06-20	CI
Shenzhen Weiguang Biological Products Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-13	CI
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for 2021	22-04-15	CI
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-13	CI
Shenzhen Weiguang Biological Products Co., Ltd. announced that it expects to receive CNY 1.15 billion in funding	22-03-08	CI

Chart Shenzhen Weiguang Biological Products Co., Ltd.

Duration

Period

Chart Shenzhen Weiguang Biological Products Co., Ltd.

More charts

SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS Co., Ltd. is a China-based high-tech company principally engaged in the research and development, production and sales of biological products. The Companyâs primary products are blood products, including the human serum albumin, human immunoglobulin, intravenous human immunoglobulin, freeze-dried intravenous human immunoglobulin, hepatitis B human immunoglobulin, Rabies immunoglobulin, tetanus immunoglobulin, histamine human immunoglobulin, and human fibrinogen. The Company mainly operates its businesses in domestic market.

Sector

Pharmaceuticals

Calendar

2024-08-15 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shenzhen Weiguang Biological Products Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

28.42 CNY

Average target price

36 CNY

Spread / Average Target

+26.67%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.	-19.10%	873M
CSL LIMITED	+2.22%	93.53B
SAMSUNG BIOLOGICS CO.,LTD.	-1.32%	38.27B
BIOGEN INC.	-13.44%	32.84B
UCB	+76.30%	27.83B
BIOMARIN PHARMACEUTICAL INC.	-13.11%	16.08B
INCYTE CORPORATION	+0.68%	14.02B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.06%	11.47B
ALTEOGEN INC.	+185.28%	9.92B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-53.00%	9.42B

Biopharmaceuticals